Neuro-Restoration Spinal Cord Injury Venture Capital Market

Neuro-restoration spinal cord injury venture capital will grow through 2036, led by early-stage funding at 52.0% share in 2026. Specialist venture funds hold 46.0% of investor type activity. Funding stands at USD 45.0 million in 2026 and is set to reach USD 356.7 million by 2036 as clinical programmes advance.